Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Merck & Co (NY:MRK)

119.66 +3.29 (+2.83%)

Streaming Delayed Price Updated: 1:25 PM EDT, Mar 25, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	4,616,866
Open	117.30
Bid (Size)	119.65 (100)
Ask (Size)	119.68 (300)
Prev. Close	116.37
Today's Range	116.80 - 120.12
52wk Range	73.31 - 125.14
Shares Outstanding	2,531,374,696
Dividend Yield	2.84%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The $6.7 Billion Pivot: A Deep Dive into Terns Pharmaceuticals (TERN) and the Merck Acquisition

Today 10:41 EDT

On this Wednesday, March 25, 2026, the biotechnology sector has been electrified by the announcement that Merck & Co. (NYSE: MRK) will acquire Terns Pharmaceuticals, Inc. (NASDAQ: TERN) in an all-cash...

Via Finterra

Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience

Today 9:35 EDT

As of March 25, 2026, Merck & Co., Inc. (NYSE: MRK) stands at a pivotal crossroads in its 135-year history. Known globally as a titan of oncology and vaccines, the Rahway, New Jersey-based...

Via Finterra

Performance

YTD	+12.4%	+12.4%
1 Month	-3.4%	-3.4%
3 Month	+13.9%	+13.9%
6 Month	+49.6%	+49.6%
1 Year	+29.6%	+29.6%

More News

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

Today 6:48 EDT

From Terns Pharmaceuticals, Inc.

Via GlobeNewswire

Merck & Co. Inc. (NYSE:MRK) Offers a Steady Dividend Backed by Strong Fundamentals ↗

March 16, 2026

Via Chartmill

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

Today 6:45 EDT

From Merck & Co., Inc.

Via Business Wire

1 S&P 500 Stock to Target This Week and 2 We Ignore

March 24, 2026

Via StockStory

Bristol-Myers Squibb Shares Jump 3.3% on Robust 2026 Guidance and High Dividend Yield

March 23, 2026

Via MarketMinute

Pfizer vs Moderna: Which Pharma Stock Has More Upside? ↗

March 19, 2026

Via The Motley Fool

FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs

March 18, 2026

From Merck & Co., Inc.

Via Business Wire

The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms

March 18, 2026

Via MarketMinute

The Grand Divergence: Finance Surges as Health Care Braces for a Historic Q1 Earnings Slump

March 17, 2026

Via MarketMinute

Merck to Present New Data Reinforcing Long-Term Efficacy of GARDASIL®9 and GARDASIL® at the EUROGIN International Multidisciplinary HPV Congress 2026

March 17, 2026

From Merck Sharp & Dohme

Via Business Wire

The mRNA Renaissance: Moderna’s 83% Surge Leads the 2026 Healthcare Recovery

March 16, 2026

Via MarketMinute

Merck & Co. Trades Ex-Dividend as Healthcare Emerges as a Volatility Hedge in 2026

March 16, 2026

Via MarketMinute

Merck Highlights New Data from Cardio-Pulmonary Pipeline at ACC.26 Showcasing Commitment to Advance Innovative Research

March 16, 2026

From Merck & Co., Inc.

Via Business Wire

1 ETF That Could Turn $100 Per Month Into $67,380 ↗

March 15, 2026

Via The Motley Fool

Flight to Quality: JPMorgan and Eli Lilly Emerge as Defensive Anchors Amid Geopolitical Storm

March 13, 2026

Via MarketMinute

The Dividend Shield: How Meta, Microsoft, Merck, and Target are Signal-Boosting Balance Sheet Strength in a Cooling 2026 Economy

March 13, 2026

Via MarketMinute

March 13, 2026

Via StockStory

BioNTech Navigates Post-Pandemic Deficit: A €17 Billion Bet on the Oncology Frontier

March 10, 2026

Via MarketMinute

Pfizer (PFE) 2026 Research Feature: The High-Stakes Pivot to Oncology and Obesity

March 10, 2026

Via Finterra

2 Dow Jones Stocks to Research Further and 1 Facing Headwinds

March 09, 2026

Via StockStory

1 Dividend Stock to Buy Hand Over Fist and 1 to Avoid ↗

March 08, 2026

Via The Motley Fool

3 Undervalued Names Too Cheap to Ignore ↗

March 07, 2026

Via MarketBeat

The Moderna Pivot: Analyzing the 14% Surge and the Future of mRNA Oncology

March 06, 2026

Via Finterra

Frequently Asked Questions

Is Merck & Co publicly traded?

Yes, Merck & Co is publicly traded.

What exchange does Merck & Co trade on?

Merck & Co trades on the New York Stock Exchange

What is the ticker symbol for Merck & Co?

The ticker symbol for Merck & Co is MRK on the New York Stock Exchange

What is the current price of Merck & Co?

The current price of Merck & Co is 119.66

When was Merck & Co last traded?

The last trade of Merck & Co was at 03/25/26 01:25 PM ET

What is the market capitalization of Merck & Co?

The market capitalization of Merck & Co is 302.90B

How many shares of Merck & Co are outstanding?

Merck & Co has 303B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.